Cryo-Cell

CCEL

----

Current ValuationThe current P/E ratio is -18.32, within the reasonable range, cheaper than 78.8% of the time in the past 3 years, and the industry ranks 52/74, the industry Median --.

-18.32xP/E

Stock price$4.42Earnings per share$-0.24

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
GHUSGuardant Health	-46.94x	2.97%	$21.28B
HIMSUSHims & Hers Health	-46.11x	209.86%	$6.55B
RDNTUSRadnet	-256.41x	128.00%	$5.41B
NEOUSNeogenomics	-41.23x	64.12%	$2.14B
WGSUSGeneDx	-17.84x	359.59%	$1.90B
AGLUSagilon health	-6.15x	92.48%	$1.43B
INNVUSInnovage	-475.99x	2,301.70%	$1.21B
OPKUSOpko Health	-15.67x	25.99%	$1.14B
LMRIUSLumexa Imaging	-37.35x	145.51%	$1.04B
CSTLUSCastle Biosciences	-50.29x	51.54%	$976.36M
FLGTUSFulgent Genetics	-6.46x	42.64%	$545.08M
GMRSUSGMR Solutions	-7.14x	91.45%	$540.22M
AONCUSAmerican Oncology Network	--	--	$372.75M
PREUSPrenetics Global	-6.76x	15.02%	$317.50M
BDSXUSBiodesix	-8.99x	42.77%	$249.64M
GAMGUSGlobal Asset Management Group, Inc.	-382.76x	--	$216.04M
NAKAUSNakamoto	-0.30x	102.50%	$127.59M
CORBFUSGlobal Cord Blood Corporation	--	--	$127.35M
AIRSUSAirSculpt Tech	-7.83x	33.33%	$91.92M
PARKUSPark Dental Partners	-25.49x	--	$90.11M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.